Literature DB >> 2209788

Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica.

T D Naotunne1, K D Rathnayake, A Jayasinghe, R Carter, K N Mendis.   

Abstract

The infectivity of Plasmodium cynomolgi in its natural host, the toque monkey, Macaca sinica, to Anopheles tessellatus mosquitoes was studied in relation to the evolution of anti-sexual-stage immunity in the host during the course of a blood-induced infection. The effects of serum on the infectivity of gametocytes and the intrinsic infectivity of gametocytes to mosquitoes on each day were assessed in membrane feeding experiments. Mosquitoes were also directly fed on the animal on each day. Our results demonstrate that during the very early patent period, before the peak of gametocytemia, the infection serum enhanced the infectivity of gametocytes up to two to three times above their infectivity in normal monkey serum. Subsequently, serum drawn post-peak of parasitemia ceased to enhance, and began to suppress, infectivity. After 2-3 months, long after parasitemias ceased patency, the serum no longer suppressed and between 3 and 4 months the serum again tended to enhance gamete infectivity before losing any significant effect. Serum infectivity enhancing effects were consistent with low indirect immunofluorescence test antibody titers against blood stage parasites first during the very early days of a blood infection before reaching blocking levels, and again during convalescence when antibodies were declining. The serum infectivity blocking effects on gametocytes were seen at the peak of antibody titers from about Days 9 to 23 of an infection. From 78 to 95% of the total infectivity of the parasite to mosquitoes during an infection occurred when infectivity enhancing activity was present in the serum. Hence, the infectivity of the parasite to mosquitoes was largely dependent on infectivity enhancing antibodies in host serum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209788     DOI: 10.1016/0014-4894(90)90035-b

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  11 in total

1.  A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area.

Authors:  A P De Zoysa; C Mendis; A C Gamage-Mendis; S Weerasinghe; P R Herath; K N Mendis
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Targeting molecular interactions essential for Plasmodium sexual reproduction.

Authors:  Joel Vega-Rodriguez; Davinia Perez-Barreto; Antonio Ruiz-Reyes; Marcelo Jacobs-Lorena
Journal:  Cell Microbiol       Date:  2015-05-29       Impact factor: 3.715

4.  Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Leonardo Rocha; Diego Alvarez; John C Beier; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

5.  Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria.

Authors:  K L Perera; S M Handunnetti; I Holm; S Longacre; K Mendis
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 6.  Non-Human Primate Malaria Infections: A Review on the Epidemiology in Malaysia.

Authors:  Nor Diyana Dian; Mohd Amirul Fitri A Rahim; Sherwin Chan; Zulkarnain Md Idris
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

7.  Population biology of malaria within the mosquito: density-dependent processes and potential implications for transmission-blocking interventions.

Authors:  Thomas S Churcher; Emma J Dawes; Robert E Sinden; George K Christophides; Jacob C Koella; María-Gloria Basáñez
Journal:  Malar J       Date:  2010-11-04       Impact factor: 2.979

8.  Humoral immunity prevents clinical malaria during Plasmodium relapses without eliminating gametocytes.

Authors:  Chester J Joyner; Cristiana F A Brito; Celia L Saney; Regina Joice Cordy; Maren L Smith; Stacey A Lapp; Monica Cabrera-Mora; Shuya Kyu; Nicolas Lackman; Mustafa V Nural; Jeremy D DeBarry; Jessica C Kissinger; Mark P Styczynski; F Eun-Hyung Lee; Tracey J Lamb; Mary R Galinski
Journal:  PLoS Pathog       Date:  2019-09-19       Impact factor: 6.823

Review 9.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

10.  Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections.

Authors:  Jacobus C de Roode; Richard Culleton; Andrew S Bell; Andrew F Read
Journal:  Malar J       Date:  2004-09-14       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.